AxoGen Newsroom

CCORF Maintains AxoGen(AXGN.US) With Buy Rating, Maintains Target Price $17

Futu NewsNov 8 22:31

JMP Securities Maintains AxoGen(AXGN.US) With Buy Rating, Maintains Target Price $20

Futu NewsNov 8 14:31

Raymond James Maintains AxoGen(AXGN.US) With Buy Rating, Raises Target Price to $18

Futu NewsNov 8 03:31

JMP Securities Maintains Market Outperform on Axogen, Raises Price Target to $20

BenzingaAug 9 19:04

Axogen Analyst Ratings

BenzingaAug 9 19:04

Buy Rating Affirmed for AxoGen: Strong Q2 Performance and Strategic Leadership Amidst Market Growth Potential

TipRanksAug 9 12:59

Axogen Analyst Ratings

BenzingaJul 1 18:10

Raymond James Initiates Coverage On Axogen With Outperform Rating, Announces Price Target of $13

BenzingaJul 1 18:10

Axogen Analyst Ratings

BenzingaJun 21 00:12

Canaccord Genuity Reiterates Buy on Axogen, Maintains $15 Price Target

BenzingaJun 21 00:12

Buy Rating Upheld for AxoGen Amid Strong Financials and Innovative Growth Strategy

TipRanksMay 9 13:11

Axogen's Strong Growth Prospects and Positive Analyst Outlook Prompt Buy Rating and Increased Price Target

TipRanksMar 7 12:21

Buy Rating Affirmed: AxoGen's Robust Growth and Market Potential Drive Positive Outlook

TipRanksMar 6 13:45

Buy Rating Affirmed for AxoGen on Strong Clinical Results and Encouraging Sales Performance

TipRanksJan 23 04:17

Cantor Fitzgerald Reiterates Overweight on Axogen, Maintains $12 Price Target

BenzingaJan 19 22:24

Axogen Analyst Ratings

BenzingaJan 19 22:23

Analysts Offer Insights on Healthcare Companies: ScPharmaceuticals (SCPH), Alnylam Pharma (ALNY) and AxoGen (AXGN)

TipRanksJan 9 14:10

Buy Rating Affirmed for AxoGen on Strong Growth and Promising Market Prospects

TipRanksJan 5 23:46

Canaccord Genuity Reiterates Buy on Axogen, Maintains $11 Price Target

BenzingaDec 7, 2023 23:44

Axogen Analyst Ratings

BenzingaDec 7, 2023 23:43